Why Theriva Biologics Are Trading Higher By Over 76%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Several stocks are experiencing significant pre-market movements. Theriva Biologics (TOVX) surged 76.4% after receiving Orphan Drug Designation from the FDA for a pancreatic cancer treatment. iMedia Brands (IMBI) gained 55.1% following a second Nasdaq non-compliance notice. National CineMedia (NCMI) rose 12.8% after its reorganization plan was confirmed by the US Bankruptcy Court. Biodexa Pharmaceuticals (BDRX) rose 12.5% after announcing a share ratio change. On the downside, AST SpaceMobile (ASTS) fell 22.6% after pricing an upsized offering of Class A common stock, and Lordstown Motors (RIDE) fell 13.1% after filing for Chapter 11 bankruptcy protection.
June 28, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AST SpaceMobile fell 22.6% after pricing an upsized offering of Class A common stock.
AST SpaceMobile's decision to price an upsized offering of Class A common stock could dilute existing shares, leading to a decrease in the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Lordstown Motors fell 13.1% after filing for Chapter 11 bankruptcy protection.
Lordstown Motors' decision to file for Chapter 11 bankruptcy protection is a negative signal for investors, indicating financial distress and uncertainty about the company's future, which could drive the stock price down in the short term.
CONFIDENCE 95
IMPORTANCE 95
RELEVANCE 100
POSITIVE IMPACT
iMedia Brands gained 55.1% following a second Nasdaq non-compliance notice.
Despite the non-compliance notice, iMedia Brands' stock price has risen significantly. This could be due to investors seeing potential value in the company or anticipating a turnaround strategy.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
National CineMedia rose 12.8% after its reorganization plan was confirmed by the US Bankruptcy Court.
The confirmation of National CineMedia's reorganization plan by the US Bankruptcy Court is a positive signal for investors, indicating that the company is making progress in its recovery efforts, which could drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Theriva Biologics surged 76.4% after receiving Orphan Drug Designation from the FDA for a pancreatic cancer treatment.
The FDA's Orphan Drug Designation is a significant positive development for Theriva Biologics, likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100